| Website | genalyte.com |
| @genalyte | |
| Category | BioTech |
| Phone | 858.259.4363 |
| sales@genalyte.com | |
| Employees | |
| Founded | 2007 |
| TOTAL | $11.8M |
| FUNDING TOTAL | $11.8M |
| Series B, 3/12 Claremont Creek Ventures | $11.8M |
Genalyte, Inc., a San Diego, CA-based life sciences company developing and commercializing innovative next-generation multiplexing technology. Founded in 2007 and led by CEO and founder Cary Gunn, Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.
